Paydirt
TP
Insider

Third Rock Ventures VI, L.P.

10% owner

Third Rock Ventures VI, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $17.2M of RAPP (426,005 sh × $40.32, as filed), executed Apr 17.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$28.3M
shares × price, as filed
Last traded
May 8
Filed May 11

Median ADV $17.2M across their filed names

Open performance
Volume by month
$17.2M$8.6M$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · sells $17.2MMay 2026 · sells $11.1M
Buys $0 Sells $28.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
RAPP Rapport Therapeutics, Inc. RAPP · 0 buys · 2 sells 2 filings
Recent filings
RAPPSALE Rapport Therapeutics, Inc. View filing → $11.1M
276,513 sh across 2 lots
Exec May 7
Filed May 11 · 5:30 PM ET
RAPPSALE Rapport Therapeutics, Inc. View filing → $17.2M
426,005 sh × $40.32
Exec Apr 17
Filed Apr 21 · 5:30 PM ET